Skip to main content
Skip to section navigation
Skip to footer
Back to AchieveLifeSciences.com
Investor Relations
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Contacts
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Whistleblower Information
All SEC Filings
SEC Filings
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10QSB
3
4
4/A
424B2
424B3
424B4
424B5
424B7
425
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEL AM
EFFECT
FWP
NT 10-K
NTN 10K
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
Date
Form
Description
PDF
XBRL
Pages
08/13/96
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
expand_more
EX-10.26
EX-10.27
EX-11.1
EX-11.2
EX-27
29
06/18/96
8-K
Current report filing
Documents
expand_more
EX-10.25
EX-99.1
31
05/24/96
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
Documents
expand_more
EX-99.1
EX-99.2
EX-99.3
56
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
…
Page
115
Page
116
Page
117
Page
118
Page
119
Page
120
Page
121
Page
122
Page
123
Page
124
Email Alerts
Contacts
RSS News Feed